Delivery Order 36F79720D0237-36C25024F0075
Award Date 10/16/23
Potential Completion Date 9/30/24
Potential Value $111K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG, is for the delivery of Xofigo (radium Ra 223 dichloride), a radiopharmaceutical used to treat prostate cancer. The $101,005.97 firm fixed-price delivery order was issued by the U.S. Department of Veterans Affairs (VA), under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. This multiple-award schedule contract has a potential value of $840...
- This is a firm-fixed price delivery order contract awarded by the Veterans Integrated Service Network 7 (VISN 7), a component of the U.S. Department of Veterans Affairs (VA), to Bayer Healthcare Pharmaceuticals Inc. The contract is for the supply of the radiopharmaceutical drug Xofigo (radium Ra 223 dichloride) used in the treatment of prostate cancer. The contract has a ceiling value of $1,054,154.72 and a period of performance through June 2024. Bayer Healthcare Pharmaceuticals Inc. is a...
- This is a federal contract award issued by the U.S. Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract, valued at $95,178.59, is for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) injection, which is used for the treatment of prostate cancer. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, with a...
- This is a $773,720.00 firm-fixed price delivery order contract awarded to Bayer Healthcare Pharmaceuticals Inc. by the Veterans Integrated Service Network 17 of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. This delivery order is placed against Bayer's $840 million multiple award schedule contract with the VA for pharmaceuticals and drugs. The contract has...
- This federal contract award to Bayer Healthcare Pharmaceuticals Inc. is for the delivery of Xofigo (radium Ra 223 dichloride), a pharmaceutical product used for the treatment of prostate cancer. The contract has a ceiling value of $100,001.04 and was awarded by the Department of Veterans Affairs (VA) under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is a delivery order with a firm fixed price. It does not have a set-aside designation, indicating Bayer...
- This federal contract award is for the supply of Xofigo (radium Ra 223 dichloride), a radiopharmaceutical medication used in the treatment of prostate cancer, to various federal agencies. The prime contractor, Bayer Healthcare Pharmaceuticals Inc., is a subsidiary of the global pharmaceutical company Bayer AG. The contract has an award value of $231,764.40 and an ultimate completion date of January 14, 2026. It is a delivery order contract under the Pharmaceuticals and Drugs Federal Supply...
- This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit company, for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. The contract, with a ceiling value of $302,784.30, is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The award has no set-aside designation, and the place...
- This is a federal contract award made by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract, valued at $458,110.23, is a delivery order under Bayer's $840 million multiple award Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB). The contract is for the supply of Xofigo (radium Ra 223 dichloride), a radiopharmaceutical product used in the treatment of prostate cancer. This...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG. The contract, worth $89,775.53, is for the supply of the radiopharmaceutical medication Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. The contract was awarded under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which has a potential...
- This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract is for the delivery of Xofigo (radium Ra 223 dichloride) injections, a specialized pharmaceutical product used for the treatment of prostate cancer. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and a ceiling value of $111,938.48. The...